FMC (FMC)
NYSE Market Closed
FMC Corporation is a global agricultural sciences company focused on crop protection products used by farmers to improve yields and manage pests, weeds, and disease. The company operates as a pure-play participant in agricultural inputs, with a portfolio that spans insecticides, herbicides, fungicides, seed treatments, and plant health products. Its customers include growers, distributors, and agricultural retailers across major farming regions, giving the business exposure to a wide mix of crops and geographies.
FMCβs position in the crop protection market has been shaped by internal research and past acquisitions that expanded its patented product base. The company competes with other large agricultural chemical groups by developing differentiated active ingredients, formulations, and application technologies that address evolving resistance challenges and changing regulatory requirements. Its products are used in row crops, fruits and vegetables, and specialty agriculture, making demand tied to planting decisions, pest pressure, commodity prices, and farm income trends.
A key part of FMCβs strategy is its research and development pipeline. The company invests in new synthetic chemistries as well as biological crop protection tools, an area that has gained attention as growers seek additional options with different environmental and residue profiles. FMCβs business is also influenced by global inventory cycles, weather patterns, currency movements, and the pace of product registrations. As a listed stock, FMC offers investors exposure to the long-term need for agricultural productivity, while also reflecting the cyclical and regulatory complexities of the crop inputs industry.
Last updated
- Market Cap
- 1.41B
- P/E
- β
- P/FCF
- β
- P/S
- 0.41
- Enterprise Value
- 5.55B
- Sector
- β
- Industry
- β
- Address
- 2929 WALNUT STREET, PHILADELPHIA, PA, 19104
Chitosan Market to Reach Over US$ 8.6 Billion by 2035 Driven by Green Chemistry Mandates, Pharmaceutical-Grade Demand, and Vegan Fungal Sourcing | Astute Analytica
Johnson Fistel Continues Investigation on Behalf of FMC Corporation Long-Term Shareholders
FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.41B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 5.55B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- β
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.77
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.41
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 13.3
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.62
- EPS
- -20.03
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 16.58%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- β
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- β
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -219.8M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -137.46%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -26.59%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 2.49
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.3
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.97
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.1
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.13M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 11.27
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 758.6M | 1.08B | 542.2M | 1.05B | 791.4M |
| Gross profit | 246.6M | 431.1M | 128.9M | 406.3M | 316.7M |
| Operating income | -81M | -1.42B | -396.3M | 119.8M | 58.2M |
| EBITDA | 38M | 237.8M | -58.4M | 199.9M | 119.7M |
| Net income | -281.3M | -1.72B | -569.3M | 66.7M | -15.5M |
| Basic EPS | -2.25 | -13.77 | -4.52 | 0.53 | -0.12 |
| Diluted EPS | -2.25 | -13.77 | -4.52 | 0.53 | -0.12 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 9.42B | 9.69B | 12.08B | 12.3B | 11.8B |
| Total liabilities | 7.57B | 7.59B | 8.28B | 7.87B | 7.39B |
| Total equity | 1.85B | 2.1B | 3.8B | 4.43B | 4.41B |
| Cash & equivalents | 390.9M | 584.5M | 497.7M | 438.2M | 315.3M |
| Current assets | 4.9B | 4.96B | 5.57B | 5.47B | 5.08B |
| Current liabilities | 3.77B | 3.59B | 3.61B | 3.57B | 3.31B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -616.6M | 636.8M | -208.2M | 49.5M | -558.3M |
| Investing cash flow | -16.2M | -15.3M | -33M | -13.4M | -38M |
| Financing cash flow | 442.3M | -546.1M | 303.4M | 76.6M | 552.1M |
| Change in cash | -193.6M | 86.8M | 59.5M | 122.9M | -42M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K β FMC CORP | View Filing | |
| eight k text | 8-K β 8-K | View Filing | |
| edgar index | 8-K β FMC CORP | View Filing | |
| eight k text | 8-K β 8-K | View Filing | |
| edgar index | 8-K β FMC CORP | View Filing | |
| eight k text | 8-K β 8-K | View Filing | |
| edgar index | SCHEDULE 13G β FMC CORP | View Filing | |
| edgar index | 8-K β FMC CORP | View Filing | |
| edgar index | 8-K β FMC CORP | View Filing | |
| edgar index | SCHEDULE 13G β FMC CORP | View Filing | |
| edgar index | SCHEDULE 13G β FMC CORP | View Filing | |
| eight k text | 8-K β 8-K | View Filing | |
| eight k text | 8-K β 8-K | View Filing | |
| edgar index | DEFA14A β FMC CORP | View Filing | |
| edgar index | SCHEDULE 13G/A β FMC CORP | View Filing | |
| edgar index | 8-K β FMC CORP | View Filing | |
| eight k text | 8-K β 8-K | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| form 4 | Form 4 β BRONDEAU PIERRE R | View Filing | |
| form 4 | Form 4 β Verduin Patricia | View Filing | |
| form 4 | Form 4 β MERKT STEVEN T | View Filing | |
| form 4 | Form 4 β Raines John Mitchell | View Filing | |
| form 4 | Form 4 β Pallash Robert C | View Filing | |
| form 4 | Form 4 β Oevrum Margareth | View Filing | |
| form 4 | Form 4 β Kempthorne Dirk A | View Filing | |
| form 4 | Form 4 β Johnson KLynne | View Filing | |
| form 4 | Form 4 β GREER C SCOTT | View Filing | |
| form 4 | Form 4 β Fortmann Kathy Lynn | View Filing | |
| form 4 | Form 4 β DAVIDSON CAROL ANTHONY | View Filing | |
| form 4 | Form 4 β CORDEIRO EDUARDO E | View Filing | |
| edgar index | SCHEDULE 13G/A β FMC CORP | View Filing | |
| edgar index | DEF 14A β FMC CORP | View Filing | |
| edgar index | DEFA14A β FMC CORP | View Filing | |
| edgar index | ARS β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| form 4 | Form 4 β BARRY MICHAEL F | View Filing | |
| edgar index | 3 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | PRE 14A β FMC CORP | View Filing | |
| form 3 | Form 3 β BARRY MICHAEL F | View Filing | |
| edgar index | 10-K β FMC CORP | View Filing | |
| form 4 | Form 4 β BARRY MICHAEL F | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| form 4 | Form 4 β Hugenneyer Thaisa | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| edgar index | 4 β FMC CORP | View Filing | |
| form 4 | Form 4 β Hugenneyer Thaisa | View Filing | |
| form 4 | Form 4 β Hugenneyer Thaisa | View Filing | |
| form 4 | Form 4 β Hugenneyer Thaisa | View Filing | |
| form 4 | Form 4 β Pfeiffer Nicholas | View Filing | |
| form 4 | Form 4 β Pfeiffer Nicholas | View Filing | |
| form 4 | Form 4 β Pfeiffer Nicholas | View Filing | |
| form 4 | Form 4 β Scanlan Jacqueline | View Filing | |
| form 4 | Form 4 β Rostovtsev Vsevolod | View Filing |